Pascal Zinn, M.D., Ph.D., FAANS(@pascalzinn) 's Twitter Profileg
Pascal Zinn, M.D., Ph.D., FAANS

@pascalzinn

Neurosurgeon @PittNeurosurg | Director Neurosurgical Oncology | Director Molecular Precision Therapy Lab | Entrepreneur | 🇨🇭🇺🇸

ID:1049347411917918209

linkhttp://www.neurosurgery.pitt.edu/person/pascal-o-zinn-md-phd calendar_today08-10-2018 17:14:53

243 Tweets

995 Followers

387 Following

Pitt Neurosurgery(@PittNeurosurg) 's Twitter Profile Photo

Spinal radiosurgery is a safe and highly effective long-term treatment modality for metastases to the spine that originate from breast cancer. link.springer.com/article/10.100… Roberta Sefcik Samuel Adida Suchet Taori Pascal Zinn, M.D., Ph.D., FAANS UPMC Hillman Cancer Center

Spinal radiosurgery is a safe and highly effective long-term treatment modality for metastases to the spine that originate from breast cancer. link.springer.com/article/10.100… @RobertaSefcik @SamuelAdida @SuchetTaori @pascalzinn @UPMCHillmanCC
account_circle
Serafettin Zenkin, MD(@serafettnznkn) 's Twitter Profile Photo

Check out our latest manuscript! We studied radiomic signatures to correlate with preoperative symptom severity for patients with CSM.
Huge thanks to Colen Lab, Alan Nima, MD & Pitt Neurosurgery! UCSF Neurosurgery Pascal Zinn, M.D., Ph.D., FAANS Rivka R Colen Murat Ak UPMC Radiology sciencedirect.com/science/articl…

account_circle
Ahmed Habib MD. MS.C(@AHabibMD) 's Twitter Profile Photo

Checkout our latest manuscript in which we describe the current understanding of the sex-dependent differences that affect GBM patients’ therapeutic susceptibility and overall survival. Pascal Zinn, M.D., Ph.D., FAANS Farrukh Hameed, MD, PhD
frontiersin.org/journals/oncol…

Checkout our latest manuscript in which we describe the current understanding of the sex-dependent differences that affect GBM patients’ therapeutic susceptibility and overall survival. @pascalzinn @HameedFarrukh frontiersin.org/journals/oncol…
account_circle
Natalie Sherry, PsyD, ABPP-CN, MBA(@DrNatalieSherry) 's Twitter Profile Photo

Shaping the future of neurosurgical care of complex brain tumors. Listen to Pascal Zinn, M.D., Ph.D., FAANS and I discuss how the UPMC/Pitt Brain Tumor Program offers individualized care to our patients. Pitt Neurosurgery Procirca Center for Clinical Neurophysiology UPMC Hillman Cancer Center

youtu.be/Qcg5G0KK9Qs?si…

account_circle
OpinionSite(@OpinionSite) 's Twitter Profile Photo

''This is a new approach to deepening our understanding of traumatic brain injury using engineered human-specific models.' said Pascal Zinn...' Medical Xpress Pascal Zinn, M.D., Ph.D., FAANS research.incrowdnow.com/3sKfbVp

account_circle
Ahmed Habib MD. MS.C(@AHabibMD) 's Twitter Profile Photo

Check out the latest manuscript from Pascal Zinn, M.D., Ph.D., FAANS
Lab in which we demonstrate how TP53-PTEN-NF1 depletion in human brain organoids produces a glioma phenotype.
Rivka R Colen Nduka Amankulor, MD Baoli Hu Farrukh Hameed, MD, PhD Pitt Neurosurgery
frontiersin.org/journals/oncol…

Check out the latest manuscript from @pascalzinn Lab in which we demonstrate how TP53-PTEN-NF1 depletion in human brain organoids produces a glioma phenotype. @rrcolen @NdukaAmankulor @Baoli_Hu @HameedFarrukh @PittNeurosurg frontiersin.org/journals/oncol…
account_circle
Farrukh Hameed, MD, PhD(@HameedFarrukh) 's Twitter Profile Photo

In our latest publication, Drs. Pascal Zinn, M.D., Ph.D., FAANS Georgios A. Zenonos, M.D. , Bradley Gross and Jeff Head demonstrate a multidisciplinary approach for effectively managing a complex rare case of Hurthle cell carcinoma metastasis to multiple regions. Pitt Neurosurgery Journal of Neurosurgery

account_circle
CNS(@CNS_Update) 's Twitter Profile Photo

Listen to the September Journal Club Podcast today! Hear from Dr Nader Pouratian FCNS and Pascal Zinn, M.D., Ph.D., FAANS as they discuss randomized control trials and how they support current . Tune in today and earn 1.5 CME: cns.org/podcasts

Listen to the September Journal Club Podcast today! Hear from @drpouratian and @pascalzinn as they discuss randomized control trials and how they support current #neurosurgery #guidelines. Tune in today and earn 1.5 CME: cns.org/podcasts #CNSPodcasts
account_circle